P2‐159: Identification of HPA axis dysfunction in ApoE targeted replacement mice
Helen K. Warwick(Princeton University), David Riddell(Eli Lilly (United States)), Christine Li, Julius J. Jefferson(Princeton University), R.E. Ford, Peter H. Reinhart(University of Massachusetts Amherst), Yolanda Kirksey(Princeton University), David von Schack(Pfizer (United States)), Menelas N. Pangalos(AstraZeneca (United Kingdom)), Hua Zhou(United Silicon Carbide (United States)), Zhuting Li(Princeton University)
Cited by 0
Related Papers
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
|Journal of Neuroscience|2008|351
Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts
|Current Biology|2001|302
Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226
|The Journal of Immunology|2015|264